Urinary Bladder Neoplasms: all 1,649 studies

Page 17 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.

• Celecoxib in Treating Patients With Bladder CancerCompletedNCT00006124Phase 2/3
• Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerStatus unknownNCT00006118Phase 2
• Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractCompletedNCT00006111Phase 2
• Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00006105Phase 2
• Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder CancerCompletedNCT00006034Phase 3
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractCompletedNCT00006026Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNCT00005858Phase 1
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
• Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerCompletedNCT00005086Phase 2
• Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
• Oxaliplatin in Treating Patients With Metastatic Bladder CancerCompletedNCT00004203Phase 2
• Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerCompletedNCT00004154Phase 3
• BCG Plus Interferon Alfa 2b in Treating Patients With Bladder CancerCompletedNCT00004122Phase 2
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerCompletedNCT00003930Phase 1/2
• S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder CancerTerminatedNCT00003824Phase 3
• Eflornithine in Treating Patients With Bladder CancerCompletedNCT00003814Phase 3
• Biological Therapy in Treating Patients With Bladder CancerCompletedNCT00003779Phase 3
• AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder CancerCompletedNCT00003759Phase 2
• Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerStatus unknownNCT00003725Phase 3
• Combination Chemotherapy in Treating Patients With Bladder CancerCompletedNCT00003701Phase 3
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2
• Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder CancerTerminatedNCT00003642Phase 2
• Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerTerminatedNCT00003640Phase 2
• High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder CancerCompletedNCT00003623Phase 3
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the BladderTerminatedNCT00003452Phase 2
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder CancerCompletedNCT00003175Phase 2
• Gene Therapy in Treating Patients With Advanced Bladder CancerCompletedNCT00003167Phase 1
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerCompletedNCT00003133Phase 1
• Chemotherapy in Treating Patients With Early-Stage Bladder CancerCompletedNCT00003129Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
• Surgery and BCG in Treating Patients With Bladder CancerCompletedNCT00002990Phase 3
• Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisCompletedNCT00002949Phase 1
• Combination Chemotherapy in Treating Patients With Stage II Bladder CancerCompletedNCT00002919Phase 2
• Paclitaxel in Treating Patients With Early-Stage Bladder CancerCompletedNCT00002917Phase 1/2
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00002914Phase 2
• Combination Chemotherapy in Patients With Advanced Urinary Tract CancerCompletedNCT00002684Phase 2
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520Not applicable
• Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder CancerCompletedNCT00002490Phase 3
• A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the BladderCompletedNCT00001381Phase 1

← Urinary Bladder Neoplasms overview